Monterey Bio Acquisition Stock (NASDAQ:MTRY)
Previous Close
$11.17
52W Range
$10.21 - $12.00
50D Avg
$11.21
200D Avg
$11.03
Market Cap
$48.30M
Avg Vol (3M)
$3.45K
Beta
-
Div Yield
-
MTRY Company Profile
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.